Effect of TSLC1 gene on growth and apoptosis in human esophageal carcinoma Eca109 cells987

Archives of Medical Science

Volumn 8, Issue 6, 2012, Pages 987-992

  Liang, Qi Lian ^a   Wang, Bi Rong ^b   Li, Zhou Yu ^b   Chen, Guo Qiang ^a   Zhou, Yuan ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Esophageal carcinoma; Transient transfection; TSLC1 gene

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LIPOCORTIN 5; TUMOR SUPPRESSOR IN LUNG CANCER 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; EXPRESSION VECTOR; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 84873146316     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.31251     Document Type: Article

References (16)

1. Kuramochi M, Fukuhara H, Nobukuni T, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 2001;27:427-30. (Pubitemid 32268425)
2. Liang QL, Chen GQ, Li ZY, Wang BR. Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest 2011;29:107-12.
3. Wang J, Zhang H, Bai W, Li L, Bian K, Cheng S. Promoter hypermethylation and mRNA expression of TSLC1 gene in laryngeal squamous cell carcinoma. J Fourth Mil Med Univ 2007;28:651-3.
4. Yang YX, Yang AH, Yang ZJ, Wang ZR, Xia XH. Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis. Int J Gynecol Cancer 2006;16:1868-72.
5. Yang G, He W, Cai M, et al. Loss/down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma. Int J Gynecol Cancer 2011;21:486-93.
6. Heller G, Geradts J, Ziegler B, et al. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat 2007;103:283-91. (Pubitemid 46944509)
7. Lung HL, Cheung AK, Xie D, et al. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Res 2006;66:9385-92. (Pubitemid 44623634)
8. Ando K, Ohira M, Ozaki T, et al. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation. Int J Cancer 2008;123:2087-94.
9. Qin L, Zhu W, Xu T, et al. Effect of TSLC1 gene on proliferation, invasion and apoptosis of human hepatocellular carcinoma cell line HepG2. J Huazhong Univ Sci Technolog Med Sci 2007;27:535-7.
10. Ito T, Shimada Y, Hashimoto Y, et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 2003;63:6320-6. (Pubitemid 37255179)
11. Liang QL, Wang BR, Li ZY, Chen GQ, Zhou Y. Construction of eukaryotic expression vector of TSLC1 gene. Arch Med Sci 2011;7:579-85.
12. Boles KS, Barchet W, Diacovo T, Cella M, Colonna M. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood 2005;106:779-86. (Pubitemid 41076415)
13. Mao X, Seidlitz E, Truant R, Hitt M, Ghosh H P. Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Oncogene 2004;23:5632-42. (Pubitemid 39093041)
14. Surace EI, Lusis E, Murakami Y, Scheithauer BW, Perry A, Gutmann DH. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. J Neuropathol Exp Neurol 2004;63:1015-27. (Pubitemid 39372586)
15. Sussan TE, Pletcher MT, Murakami Y, Reeves RH. Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression. Mol Cancer 2005;4:28.
16. Fukuhara H, Kuramochi M, Fukami T, et al. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res 2002;93:605-9. (Pubitemid 34846267)